Skip to content
10-K

Annual Report

Yubo International Biotech Ltd YBGJ

0001640334-26-000598

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 25, 2026 170.42M sh
Shares Diluted FY 2025 · Dec 31, 2025 139.64M sh
Shares Diluted FY 2025 · Dec 31, 2024 119.82M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$842.8K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$1.34M
Cash And Equivalents FY 2025 · Dec 31, 2025 $8.06K
Stockholders Equity FY 2025 · Dec 31, 2025 −$1.95M
Stockholders Equity FY 2025 · Dec 31, 2024 −$3.42M
Current Liabilities FY 2025 · Dec 31, 2025 $2.79M
Current Liabilities FY 2025 · Dec 31, 2024 $4.72M
Total Liabilities FY 2025 · Dec 31, 2025 $2.79M
Total Liabilities FY 2025 · Dec 31, 2024 $4.83M
Current Assets FY 2025 · Dec 31, 2025 $667.51K
Current Assets FY 2025 · Dec 31, 2024 $682.75K
Total Assets FY 2025 · Dec 31, 2025 $847.09K
Total Assets FY 2025 · Dec 31, 2024 $1.53M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.01
Eps Diluted FY 2025 · Dec 31, 2024 −$0.02
Net Income FY 2025 · Dec 31, 2025 −$1.08M
Net Income restated FY 2025 · Dec 31, 2024 −$1.78M
Operating Income FY 2025 · Dec 31, 2025 −$1.19M
Operating Income FY 2025 · Dec 31, 2024 −$1.77M
Gross Profit FY 2025 · Dec 31, 2025 $8.17K
Gross Profit FY 2025 · Dec 31, 2024 $2.65K
Cost Of Revenue FY 2025 · Dec 31, 2025 $4.19K
Cost Of Revenue FY 2025 · Dec 31, 2024 $822
Revenue FY 2025 · Dec 31, 2025 $12.35K
Revenue FY 2025 · Dec 31, 2024 $3.47K